{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:16:22Z","timestamp":1795040182442,"version":"4.10.2"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jns.2026.126173","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:12:45Z","timestamp":1790291565000},"page":"126173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antithrombotic use patterns for secondary stroke prevention in ischemic stroke patients with active malignancy: The STOP-SPAM study"],"prefix":"10.1016","volume":"491","author":[{"given":"Dylan","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie","family":"Demel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jns.2026.126173_bb0005","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011264","article-title":"Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies","volume":"96","author":"Zhang","year":"2021","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2026.126173_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106818","article-title":"Trends in age and sex-specific prevalence of cancer and cancer subtypes in acute ischemic stroke from 2007-2019","volume":"31","author":"Otite","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"23","key":"10.1016\/j.jns.2026.126173_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005636","article-title":"New diagnosis of cancer and the risk of subsequent cerebrovascular events","volume":"90","author":"Navi","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2026.126173_bb0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","article-title":"Cancer and embolic stroke of undetermined source","volume":"52","author":"Navi","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2026.126173_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/STR.0000000000000517","article-title":"Classification and Management of Ischemic Stroke in patients with active Cancer: a scientific statement from the American Heart Association","author":"Navi","year":"2026","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2026.126173_bb0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2019.11.024","article-title":"Embolic stroke of undetermined source: JACC review topic of the week","volume":"75","author":"Ntaios","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.jns.2026.126173_bb0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0043-1771270","article-title":"Ischemic stroke in cancer: mechanisms, biomarkers, and implications for treatment","volume":"50","author":"Costamagna","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"issue":"23","key":"10.1016\/j.jns.2026.126173_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16234016","article-title":"Epidemiology, pathophysiology, and management of cancer-associated ischemic stroke","volume":"16","author":"Ryan","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.jns.2026.126173_bb0045","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2026.126173_bb0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ene.14172","article-title":"Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial","volume":"27","author":"Martinez-Majander","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2026.126173_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2024.2404","article-title":"Apixaban vs aspirin in patients with Cancer and cryptogenic stroke: a post hoc analysis of the ARCADIA randomized clinical trial","author":"Navi","year":"2024","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2026.126173_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5853\/jos.2016.00570","article-title":"Hypercoagulability and mortality of patients with stroke and active Cancer: the OASIS-CANCER study","volume":"19","author":"Lee","year":"2017","journal-title":"J Stroke."},{"issue":"4","key":"10.1016\/j.jns.2026.126173_bb0065","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.jns.2026.126173_bb0070","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European cooperative acute stroke study I (ECASS I) cohort","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jns.2026.126173_bb0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident cancer and subsequent stroke","volume":"77","author":"Navi","year":"2015","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.126173_bb0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000440730","article-title":"Cancer-associated stroke: the Bergen NORSTROKE study","volume":"5","author":"Selvik","year":"2015","journal-title":"Cerebrovasc Dis Extra."},{"issue":"3","key":"10.1016\/j.jns.2026.126173_bb0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/ene.13234","article-title":"Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke","volume":"24","author":"Gon","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jns.2026.126173_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104823","article-title":"Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients","volume":"29","author":"Guo","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2026.126173_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1265715","article-title":"Association between three-territory sign and prognosis of acute ischemic stroke patients with malignancy","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.126173_bb0100","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213902","article-title":"Frequency, risk factors, and outcomes of strokes in patients with primary glioma after cranial radiation therapy","volume":"105","author":"Ryan","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2026.126173_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ohn.1249","article-title":"Stroke risk in head and neck Cancer: a Meta-analysis of reconstructed individual patient survival data","volume":"173","author":"Liew","year":"2025","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"6","key":"10.1016\/j.jns.2026.126173_bb0110","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/17474930241239266","article-title":"Edoxaban for the treatment of hypercoagulability and cerebral thromboembolism associated with cancer: a randomized clinical trial of biomarker targets","volume":"19","author":"Chung","year":"2024","journal-title":"Int. J. Stroke"},{"issue":"2","key":"10.1016\/j.jns.2026.126173_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects","volume":"11","author":"Falanga","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.jns.2026.126173_bb0120","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/trf.17569","article-title":"Lower platelet count and metastatic tumor are associated with increased risk of spontaneous bleeding in critically ill patients with cancer: an observational study","volume":"63","author":"Kayano","year":"2023","journal-title":"Transfusion"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26004557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:33:11Z","timestamp":1795037591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26004557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S0022510X26004557"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126173","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic use patterns for secondary stroke prevention in ischemic stroke patients with active malignancy: The STOP-SPAM study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126173"}}